SpineGuard released their first quarter 2015 financial report.
Here are six things to know:
1. The first quarter revenue grew 47 percent.
2. The United States revenue was up 59 percent, while revenue from the rest of the world was up 20 percent.
3. Targeted sales efforts, clinico-economic data and marketing initiatives began "bearing fruit" in the first quarter, particularly in the United States and France.
4. The French and U.S. markets represented more than 75 percent of the company's revenue.
5. Going forward, the company plans to vigorously drive sales of the PediGuard to sustain solid year-long growth.
6. There were 1,977 PediGuard units sold in the first quarter, up from 1,524 in the same quarter last year. There were 956 units sold in the United States.